However, the identification of the BCR::ABL1 fusion (considered the hallmark of CML) as the primary oncogenic event through the clonal ontogeny of these cases of acute leukemia raises several concerns. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.